Bottom line
IYH vs HCPIX: the short answer
IYH (iShares U.S. Healthcare ETF) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 68% by weight.
IYH is cheaper at 0.37% vs 1.76% — a difference of $139 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +6.4% for HCPIX (reporting dates differ).
Updated Nov 19, 2026
IYH vs HCPIX side by side
| IYH | HCPIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 1.76% |
| Annual cost per $10k | $37 | $176 |
| 10-yr cost on $10k (prospectus) | $468 | $2,073 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +13.1% | −1.4% |
| 5-yr return (annualized) | +7.0% | +6.4% |
| 10-yr return (annualized) | +9.4% | +9.2% |
| Best quarter | +15.3% | +22.0% |
| Worst quarter | −12.7% | −21.0% |
| Net assets (fund) | $3.6B | $12.1M |
| Number of holdings | 103 | 69 |
| Portfolio turnover | 3% | 99% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IYH | HCPIX | Difference |
|---|---|---|---|
| 2024 | +3.1% | −1.4% | +4.4% |
| 2023 | +2.1% | −1.3% | +3.4% |
| 2022 | −4.4% | −10.6% | +6.2% |
| 2021 | +23.4% | +33.9% | −10.5% |
| 2020 | +15.5% | +16.9% | −1.4% |
| 2019 | +20.8% | +28.4% | −7.6% |
| 2018 | +5.9% | +5.0% | +0.9% |
| 2017 | +22.3% | +32.2% | −9.9% |
| 2016 | −2.8% | −6.5% | +3.7% |
| 2015 | +6.1% | +6.4% | −0.3% |
Source: Fund prospectus bar charts
Holdings overlap
17 of IYH's top 25 holdings also appear in HCPIX's top 25.
| Holding | IYH | HCPIX |
|---|---|---|
| Eli Lilly And Company | 15.11% | 11.83% |
| Johnson & Johnson | 10.17% | 8.03% |
| Abbvie Inc. | 7.32% | 5.77% |
| Unitedhealth Group Incorporated | 6.16% | 4.90% |
| Merck & Co., Inc. | 5.31% | 4.19% |
| Thermo Fisher Scientific Incorporated | 3.52% | 2.78% |
| Amgen Inc. | 3.42% | 2.71% |
| Abbott Laboratories | 3.02% | 2.40% |
| Gilead Sciences, Inc. | 2.66% | 2.10% |
| Pfizer Inc. | 2.35% | 1.86% |
| Bristol-myers Squibb Company | 2.20% | 1.74% |
| Intuitive Surgical, Inc. | 2.05% | 1.63% |
| Danaher Corporation | 2.03% | 1.60% |
| Vertex Pharmaceuticals Incorporated | 2.00% | 1.57% |
| Stryker Corporation | 1.86% | 1.46% |
Source: SEC Form N-PORT
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FAQ
What is the difference between IYH and HCPIX?
Which is cheaper, IYH or HCPIX?
Should I own both IYH and HCPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.